Real-World Study Confirms Efficacy of Venetoclax Alone, After BTKi Therapy in CLL
Researchers found that venetoclax, either alone or post treatment with a Bruton tyrosine kinase inhibitor (BTKi), was safe and effective for patients with chronic lymphocytic leukemia (CLL).
United States American Society Of Hematology Annual Meeting Exposition American Society Hematology Annual Meeting Real World Evidence Cll Sll
Source: ajmc.com